Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Tokyo Joe's Cafe / Societe Anonyme/No Pennies -- Ignore unavailable to you. Want to Upgrade?

To: ilh1 who wrote (48372)	1/28/1999 12:33:00 AM
From: TsioKawe	Respond to of 119973

thanks prosperous one..

To: ilh1 who wrote (48372)	1/28/1999 12:33:00 AM
From: GBT	Respond to of 119973

Paragraph from press release: Preliminary results suggest that when used once a day during the cold season, ZICAM will effectively protect against the common cold. ZICAM is developed by and manufactured for Gel Tech, Inc. (a joint venture by BIODELIVERY Technologies, Inc., a privately-held biotechnology company, and GumTech International, Inc., a publicly-held company located in Phoenix, Ariz.). Gel Tech's mission is to develop and provide innovative products that change consumers' expectations for the over-the-counter products they need and use. For more information on ZICAM, visit Gel Tech's web site at JOINT VENTURE